Phase I Trial of Etoposide, Doxorubicin and Cisplatin (EAP) in Combination with GM-CSF

By Ford P.A.   Arbuck S.G.   Minniti C.   Miller L.L.   DeMaria D.   O'Dwyer P.J.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 631-635

Elsevier

Access to resources Recommend Favorite

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1208-1212

Science Publishers

Access to resources Recommend Favorite

Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF - results of a prospective randomised trial

By Hejna M.   Kostler W.J.   Raderer M.   Steger G.G.   Brodowicz T.   Scheithauer W.   Wiltschke C.   Zielinski C.C.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 1994-2002

Elsevier

Access to resources Recommend Favorite

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

By Sparano Joseph   Negassa Abdissa   Lansigan Erick   Locke Robin   Silva Chamath   Wiernik Peter  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 257-267

Humana Press, Inc

Access to resources Recommend Favorite

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma

By Abalı Huseyin   Urun Yuksel   Oksuzoğlu Berna   Budakoğlu Burcin   Yıldırım Nuriye   Guler Tunc   Ozet Gulsum   Zengin Nurullah  

Cancer Investigation, Vol. 26, Iss. 4, 2008-05 ,pp. : 401-406

Informa Healthcare

Access to resources Recommend Favorite